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It has been reported that human cytomegalovirus (HCMV) miR-US25-2 reduces DNA viral replication
including HCMV. However, the mechanism remains unknown. In our study, eukaryotic translation
initiation factor 4A1 (eIF4A1) was identiﬁed to be a direct target of miR-US25-2-3p. Small interfering
RNA (siRNA) and miR-US25-2-3p mediated eIF4A1 knockdown experiments revealed that high level
of miR-US25-2-3p in MRC-5 cells decreased HCMV and host genomic DNA synthesis, and inhibited
cap-dependent translation and host cell proliferation. However, eIF4A1 up-regulation induced by
miR-US25-2-3p inhibitor increased HCMV copy number. Therefore, the over-expression of miR-
US25-2-3p and consequent lower expression of eIF4A1 may contribute to the inhibition of HCMV
replication.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Human cytomegalovirus (HCMV) is a b-herpesvirus that causes
widespread, persistent human infection. MicroRNAs (miRNAs) are
endogenous, non-coding RNA of about 22 nucleotides that regu-
lates gene expression by controlling target mRNA translation or
degradation [1]. So far, at least 19 miRNAs have been identiﬁed
in HCMV [2]. Emerging evidences suggest that some HCMV miR-
NAs may regulate viral replication and play signiﬁcant roles in
determining the viral life cycle [3–5]. It has been reported that
over-expression of miR-US25-2 can reduce the viral replication
and DNA synthesis of DNA viruses including HCMV, and thus the
authors hypothesized that miR-US25-2 could target host genesthat are essential for virus replication [3]. However, the mecha-
nism remains illusive.
In this study, we found that over-expression of miR-US25-2-3p,
which is one miRNA derived from the precursor of miR-US25-2,
obviously reduce HCMV replication. The targets of miR-US25-2-
3p were screened using hybrid-PCR method [6], and eukaryotic
translation initiation factor 4A1 (eIF4A1), an ATP-dependent RNA
helicase, which plays an important role in cap-dependent transla-
tion, cell proliferation and viral growth [7–14], was identiﬁed as a
direct target of miR-US25-2-3p by luciferase reporter assay and
functional analyses.
2. Materials and methods
2.1. Cell culture and virus
Human fetal diploid lung ﬁbroblasts MRC-5 cells were main-
tained in modiﬁed Eagle’s medium (MEM) with 10% fetal bovine
serum (FBS), 100 units/ml penicillin and 100 units/ml streptomy-
cin. HCMV clinical strain Han was isolated from a urine sample
of a 5-month-old infant hospitalized in Shengjing Hospital of China
Medical University. The virus was inoculated in MRC-5 cells main-
tained in MEM supplemented with 2% FBS and penicillin–strepto-
mycin, then the cell lysate containing virus was harvested and
stored at 80 C.
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Stock virus was inoculated in MRC-5 at a multiplicity of infec-
tion (MOI) of 3–5 PFU per cell. To carry out early infection condi-
tion, 100 lg/ml phosphonoacetic acid (PAA) was added to the
medium as the some time as virus inoculation. The MRC-5 cells
were harvested at 48 h post infection (hpi) and total RNA was ex-
tracted with TRIzol (Invitrogen) and treated by TURBO DNA-freeTM
Kit (Ambion). Hybrid-PCR, an effective miRNA target screening
method established in our laboratory [6], was carried out to screen
putative targets of miR-US25-2-3p (Supplementary Fig. 1). A spe-
ciﬁc hybrid-primer of miR-US25-2-3p, 50-GCGGGRGCTCTCCRR
GTGGR-30, was designed as follow: a reverse and complementary
sequence of miR-US25-2-3p seed region (nucleotides 2–8) was lo-
cated in the 30-terminal of the hybrid-primer; R in the primer rep-
resents adenine (A) or guanine (G) due to G:U pair is allowed for
the formation of miRNA:mRNA duplexes as described in the miR-
anda database (http://www.microrna.org/microrna/getMirna-
Form.do). After reverse transcription using 30-Full RACE Core Set
kit (TaKaRa), sequences between miR-US25-2-3p binding sites
and polyA signal were ampliﬁed with the hybrid-primer, the outer
primer (50-TACCGTCGTTCCACTAGTGATTT-30) and the inner primer
(50-CGCGGATCCTCCACTAGTGATTTCACTATAGG-30) provided in the
kit. All PCR products were cloned into pMD 18-T vectors (TaKaRa),
and were sequenced on an ABI 3730 automated sequencer. mRNA
speciﬁc sequences located between the miR-US25-2-3p hybrid-
primer, which is homologous to the miRNA binding site, and polyA
tails were intercepted and used to identify the putative target
genes (http://www.ncbi.nlm.nih.gov/blast).2.3. Plasmid construction
30-untranslated region (30-UTR) of eIF4A1 containing putative
binding sites for miR-US25-2-3p was ampliﬁed from MRC-5 gen-
ome DNA (primers: sense, 50-GGACTAGTGAACATTTTAGACAC
CCTTTT-30 and reverse, 50-CCCAAGCTTGTTTCCAAGTCATTTTATTCA
GA-30), and cloned into the Spe I and Hind III sites of pMIR-REPORT
ﬁreﬂy luciferase (FFL) vector (Promega), named as pMIR-eIF4A1-
UTR. Mutant 30-UTR of eIF4A1 was constructed using two-step
multi-site mutagenesis PCR (primers are listed in Supplementary
Table), which generated a mutation of 7 bps from CCAGGUGG to
GUGCGGCA in the predicted miR-US25-2-3p binding site. Recombi-
nant plasmid containing the mutant 30-UTR was named as pMIR-
eIF4A1-UTRM. According to the small interfering RNA (siRNA) se-
quence of eIF4A1, 50-CUGGCCGUGUGUUUGAUAUGC-30 [9], two oli-
gonucleotides were designed and synthesized to form the hairpin
siRNA template: 50-GATCCGGCCGTGTGTTTGATATGCTTCAAGAGA
GCATATCAAACACACGGCCAGA-3’ and 50-AGCTTCTGGCCGTGTGTT
TGATATGCTCTCTTGAAGCATATCAAACACACGGCCG-30. The annealed
double strand template with adherent ends was cloned into the
BamHI and HindIII sites of pSilencer 4.1-CMV vector (Ambion), and
was named as sieIF4A1. All constructs were conﬁrmed by DNA
sequencing.2.4. Virus DNA quantiﬁcation
MRC-5 cells transfected with 60nM precursor molecules of miR-
US25-2-3p (Ambion) or scrambled sequence pre-miR negative con-
trol (pre-miR-NC, Ambion) or speciﬁc microFF™ miR-US25-2-3p
inhibitor (RiboBio), or 4 lg sieIF4A1 were infected with HCMV
Han strain at MOI of 0.5 in 6-well plates. Lipofectamine 2000
(Invitrogen) was used for transfection as described by Matsuura
et al. [15]. In the indicated time points, total cellular DNA was ex-
tracted for HCMV DNA quantiﬁcation. The viral DNA copies were
determined by ﬂuorescence quantitative real-time polymerasechain reaction (qPCR) using a commercially available HCMV diag-
nostic kit (Da An Gene) [16].
2.5. RT-qPCR for miRNA quantiﬁcation
Total RNA was isolated from virus infected cells with TRIzol
(Invitrogen) and treated by TURBO DNA-free™ Kit (Ambion). Re-
verse transcription (RT) was performed using TaqMan miRNA re-
verse transcription kit (Applied Biosystems) and small RNA-
speciﬁc primers of miR-US25-2-3p or small nucleolar RNA (snRNA)
U6 (control) (Applied Biosystems). qPCR was carried out to mea-
sure the expression of mature miR-US25-2-3p and U6 using Uni-
versal PCR Master Mix Kit (Applied Biosystems) and speciﬁc
TaqMan probe (Applied Biosystems) following the manufacture’s
instructions. The relative expression level of miR-US25-2-3p was
normalized to U6 RNA by 244CT methods [17].
2.6. 30-UTR luciferase reporter assay
MRC-5 cells were cultured in 24-well plates and transfected
with 100 ng pMIR-eIF4A1-UTR or pMIR-eIF4A1-UTRM together with
100 ng pRL-TK-Renilla-luciferase plasmid (Promega) and 60 nM
pre-miR-US25-2-3p or pre-miR-NC. 48 h later, luciferase activities
were measured using Dual Luciferase Reporter Assay System (Pro-
mega) according to the manufacturer’s instructions. FFL activity
was normalized to renilla luciferase activity.
2.7. Western blotting
MRC-5 cells in 60 mm plates were lysed and protein was har-
vested using PIPA buffer (Beyotime). Total protein levels were
determined by bicinchoninic acid (BCA) analysis (Beyotime). Equal
amount of the extracts were subjected to SDS–PAGE, transferred
onto nitrocellulose membranes, and then protein was detected
using primary antibodies speciﬁc to eIF4A1 (Abcam) or b-actin
(Santa Cruz), and horseradish peroxidase (HRP)-conjugated sec-
ondary antibodies (Zhong Shan) with ECL regent (GE Bioscience).
2.8. Translation assay
For cap-dependent in vivo translation assay, relative FFL activity
to its mRNA quantity was detected. 100 ng pMIR-REPORT lucifer-
ase vector and 60 nM pre-miR-US25-2-3p or pre-miR-NC or
0.8 lg sieIF4A1 were co-transfected into MRC-5 cells of 24-well
plates. Luciferase activity was measured at 48 h and normalized
to FFL mRNA levels. FFL cDNA copy number, as a measurement
for its mRNA content, was determined by RT-qPCR using SYBR Pre-
mix Ex Taq kit (TaKaRa), and the pMIR-REPORT plasmid DNA was
used as a standard. The primers for FFL cDNA detection were de-
signed as reported before [18].
2.9. Cell proliferation assay
The in vitro cell proliferation was determined by 3-(4,5-dimeth-
ylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay.
1  104 cells/well of MRC-5 were seeded into 96-well plates, and
were transfected with 60 nM pre-miR-US25-2-3p or pre-miR-NC
or 0.2 lg sieIF4A1, respectively. At 0 h, 24 h, 48 h, and 72 h post
transfection, 20 ll of 5 mg/ml MTT (Sigma) was added to the media
and kept for 4 h incubation at 37 C. Following removal of the cul-
ture medium, the remaining crystals were dissolved in 200 ll
DMSO (Sigma) and the absorbance at 490 nm was measured.
2.10. Genome DNA quantiﬁcation
To detect the genome DNA synthesis levels of host cells, MRC-5
were plated in 6-well plates, and transfected with 60 nM pre-miR-
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tracted at 48 and 72 h post transfection using TIANamp Genomic
DNA Kit (TIANGEN). The DNA quantities were estimated based
on the volume and concentrations measured by the absorbance
at 260 nm.2.11. Statistics
Data are shown as mean ± SE. Statistical signiﬁcance was deter-
mined by Student’s t-test, with P-value of <0.05 considered to be
statistically signiﬁcant.Fig. 1. miR-US25-2-3p inhibits eIF4A1 expression by targeting eIF4A1 30-UTR. (A)
Schematic diagram of predicted target site of miR-US25-2-3p in the eIF4A1 30-UTR.
The predicted binding site of miR-US25-2-3p is indicated in the 386–413 of the
eIF4A1 30-UTR. The ﬁrst nucleotide after the stop codon of eIF4A1 is deﬁned as ‘‘1’’.
(B) Dual luciferase assay with cotransfection of the reporter vectors containing the
wild type eIF4A1 30-UTR (Wt) or mutant type eIF4A1 30-UTR (Mut) or PMIR-REPORT
vector, and pre-miR-NC or pre-miR-US25-2-3p in MRC-5 cells. The assays were
performed in triplicate. ⁄P < 0.01. (C) Western blot analysis of eIF4A1 protein
expression after transfection of pre-miR-NC or pre-miR-US25-2-3p in MRC-5 cells.3. Results
3.1. Over-expression of miR-US25-2-3p reduces HCMV DNA
replication
To validate the effect of miR-US25-2-3p on HCMV DNA replica-
tion, MRC-5 cells transfected with pre-miR-US25-2-3p or pre-miR-
NC were infected by HCMV Han strain. As shown in Supplementary
Fig. 2, over-expression of miR-US25-2-3p resulted in signiﬁcant
reductions of HCMV DNA compared with pre-miR-NC transfected
cells at 96 hpi.
3.2. eIF4A1 is a direct target of miR-US25-2-3p
Using hybrid-PCR, 17 candidate target mRNAs were obtained
from 68 sequenced clones (Table 1). One was from HCMV genome
and the others were from human genome. Among the candidate
targets, only eIF4A1 has been reported to be positively associated
with viral replication [11–14]. eIF4A1 30-UTR has one putative
target site of miR-US25-2-3p, which is also predicted by RNAhy-
brid (http://bibiserv.techfak.uni-bielefeld.de/rnahybrid/submis-
sion.html) (Fig. 1A).
To validate whether or not eIF4A1 is a direct target of miR-
US25-2-3p, luciferase reporter assay and western blot were per-
formed. As shown in Fig. 1B, cotransfection of pMIR-eIF4A1-UTR
with pre-miR-US25-2-3p resulted in a signiﬁcant decrease
(60%) in luciferase activity; However, mutation of the miR-
US25-2-3p binding site (Supplementary Fig. 3) in the eIF4A1 30-
UTR abolished this effect of miR-US25-2-3p. Moreover, ectopicTable 1
Putative miR-US25-2-3p targets identiﬁed by hybrid-PCR.
Putative target mRNA Accession
Number
Echinodermmicrotubule associated protein like 2 (EML2) NM_001193268.1
Chaperonin containing TCP1, subunit 8 (theta) (CCT8) NM_006585.2
Eukaryotic translation initiation factor 4A, isoform 1
(eIF4A1)
NM_001204510.1
Ornithine decarboxylase antizyme 1 (OAZ1) NM_004152.2
Thioredoxin domain containing 12 (TXNDC12) NM_015913.2
Zinc ﬁnger protein 248 (ZNF248) NM_021045.1
Immediate early response 3 (IER3) NM_003897.3
Cytochrome c oxidase subunit IV isoform 1 (COX4I1) NM_001861.3
Oral-facial-digital syndrome 1(OFD1) NM_003611.2
Transforming growth factor, beta-induced, 68 kDa
(TGFBI)
NM_000358.2
Neighbor of BRCA1 gene 1 (NBR1), transcript variant 2 NM_031858.2
TSPY-like 2 (TSPYL2) NM_022117.3
Prefoldin subunit 1 (PFDN1) NM_002622.4
Ribosomal protein L4 (RPL4) NM_000968.3
versican (VCAN), transcript variant 3 NM_001164097.1
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) NM_002046.3
HCMV UL144 FR677246.1expression of miR-US25-2-3p markedly reduced the endogenous
eIF4A1 protein expression in MRC-5 cells (Fig. 1C). These data
demonstrate that miR-US25-2-3p inhibits eIF4A1 expression di-
rectly by targeting eIF4A1 30-UTR.
3.3. miR-US25-2-3p reduces HCMV replication by inhibiting eIF4A1
expression
To determine whether eIF4A1 inhibition caused by miR-US25-2-
3p could affect HCMV DNA synthesis, the expression of miR-US25-
2-3p and eIF4A1, as well as HCMV copy numbers were detected in
MRC-5 cells infected by HCMV Han strain during natural infection
or after transfection of pre-miR-US25-2-3p, miR-US25-2-3p inhib-
itor, and sieIF4A1, respectively. As expected, transfection of pre-
miR-US25-2-3p into MRC-5 cells resulted in substantially increase
of miR-US25-2-3p expression compared to untreated cells (347-
fold, 602-fold and 815-fold at 24, 48, and 72 hpi, respectively),
while, miR-US25-2-3p expression was effectively blocked (0.02-
fold, 0.03-fold and 0.17-fold at 24, 48, and 72 hpi, respectively)
in miR-US25-2-3p inhibitor-transfected cells (Fig. 2A). The data
showed that the natural expression of eIF4A1 in HCMV infected
MRC-5 cells was upregulated compared with un-infected cells
(Fig. 2B), and miR-US25-2-3p expression (Fig. 2A) and HCMV copy
number were also exhibited time-dependent increase (Fig. 2C).
However, miR-US25-2-3p inhibitor mediated miR-US25-2-3p si-
lence in infected MRC-5 cells induced increased eIF4A1 expression
at 48 and 72 hpi compared with the untreated cells (Fig. 2B), and
the corresponding HCMV copy number was also increased (1-
fold) (Fig. 2C). Moreover, decrease of eIF4A1 expression caused
by miR-US25-2-3p (Fig. 2B) and eIF4A1 siRNA (Supplementary
Fig. 4) markedly reduced HCMV DNA levels (Fig. 2C). These results
indicated that miR-US25-2-3p may reduce HCMV replication by
inhibiting eIF4A1 expression.
Fig. 2. miR-US25-2-3p reduces HCMV growth by suppressing eIF4A1 expression (A) MRC-5 cells were transfected with pre-miR-US25-2-3p (25) or miR-US25-2-3p inhibitor
(Inhi), and then were infected with HCMV Han at MOI, 0.5. At 24, 48, 72 hpi, mature miR-US25-2-3p was evaluated by TaqMan RT-qPCR, and normalized to that of
untransfected cells (Untreated, UN) at 24hpi. The assays were performed in triplicate. ⁄P < 0.01. (B) MRC-5 cells were treated as (A). At 0, 24, 48, 72 hpi, Western blot analysis
of eIF4A1 protein expression was performed. (C) MRC-5 cells were transfected with pre-miR-US25-2-3p or miR-US25-2-3p inhibitor or eIF4A1 siRNA, and then were infected
with HCMV Han at MOI, 0.5. At 24, 48, 72 hpi, viral DNA copy number was evaluated by RT-qPCR, and normalized to that of untransfected cells at 24 hpi. The assays were
performed in triplicate. ⁄P < 0.05; ⁄⁄P < 0.01.
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Given the well-established role of eIF4A1 in translation initia-
tion, a putative effect of miR-US25-2-3p on translation was exam-
ined by FFL reporter assay. To directly measure the effect on
protein synthesis and avoid bias by variations in transfection efﬁ-
ciencies or mRNA turnover, luciferase activity was normalized to
luciferase mRNA levels. As expected, ectopic expression of miR-
US25-2-3p, as well as knockdown of eIF4A1 by eIF4A1 siRNA in
MRC-5 cells led to an approximate 68% and 70% decrease in the
luciferase activity, respectively, compared to cells transfected withpre-miR-NC (Fig. 3). Therefore, miR-US25-2-3p may inhibit cellular
translation by down-regulating eIF4A1.
3.5. miR-US25-2-3p suppresses host cell proliferation and genomic
DNA synthesis
The effect of miR-US25-2-3p on host cell proliferation and
genomic DNA synthesis were evaluated by MTT and quantiﬁcation
of genomic DNA. As shown in Fig. 4A, the pre-miR-US25-2-3p- and
eIF4A1 siRNA-transfected MRC-5 cells exhibited signiﬁcant growth
suppression compared with the pre-miR-NC-transfected cells.
Fig. 3. miR-US25-2-3p inhibits eIF4A1-dependent translation. The FFL activity was
normalized to the luciferase mRNA level. The data detected in MRC-5 cells
expressing miR-US25-2-3p and eIF4A1 siRNA was normalized to pre-miR-NC
transfected MRC-5 cells. The assays were performed in triplicate. ⁄P < 0.01.
Fig. 4. miR-US25-2-3p inhibits cell proliferation and genomic DNA synthesis. In
vitro cell proliferation assays after eIF4A1 knockdown by pre-miR-US25-2-3p or
siRNA in MRC-5 cells. The control cells were transfected with NC. The measure-
ments were performed in triplicate. (B) The genomic DNA content in MRC-5 cells
transfected as (A) was detected at 48 and 72 h post transfection, and normalized to
that of pre-miR-NC transfected cells. The measurements were performed in
triplicate. ⁄P < 0.05; ⁄⁄P < 0.01.
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siRNA transfection also signiﬁcantly reduced genomic DNA synthe-
sis of MRC-5 cells compared to the control cells (Fig. 4B). These re-
sults suggested that miR-US25-2-3p may mediate inhibition of cell
growth and genomic DNA synthesis in an eIF4A1-dependent man-
ner in MRC-5 cells.4. Discussion
The discovery of small non-coding regulatory RNA molecules
known as miRNAs is undoubtedly one of the most important ﬁnd-
ings in biological research in eukaryotic organisms and viruses,
particularly in cytomegalovirus. miRNAs are non-immunogenic,
so they may act as stealthy tools for viruses to regulate their as
well as host gene expression.
HCMV miR-US25-2-3p is encoded by the intergenic region be-
tween US24 and US26, and forms the 30 arm of the pre-miR-
US25-2 stem-loop structure [19]. However, the functional knowl-
edge about miR-US25-2-3p is very limited. Only one report from
Stern-Ginossar et al. [3] indicated that miR-US25-2 reduced viral
replication and DNA synthesis not only of HCMV but also of other
DNA viruses (herpes simplex virus 1 and an adenovirus), but the
mechanism is unknown. Our data further conﬁrms that over-
expression of miR-US25-2-3p, one miRNA derived from the precur-
sor of miR-US25-2, can obviously inhibit HCMV DNA replication.
In our study, a host gene, eIF4A1, was screened out by hybrid-
PCR and predicted by RNAhybrid to be a candidate target of miR-
US25-2-3p. Literature review indicates that maintenance of cap-
dependent translation is essential for DNA virus replication [11–
14]. Due to the absence of their own translational machinery,
HCMV must gain access to host cell ribosomes to synthesize their
own proteins. eIF4A1, as an ATP-dependent RNA helicase, is crucial
for the assembly of the translational active ribosome. eIF4A1 can
unwind RNA secondary structures in the 50-UTR of mRNAs which
is necessary to allow efﬁcient binding of the small ribosomal sub-
unit, and subsequent scanning for the initiator codon [20]. eIF4A1,
together with a cap-binding protein eIF4E [21] and a large scaffold-
ing protein eIF4G [22], forms the translation initiation complex
eIF4F [23,24], which recruits the 40S subunit to the 50 cap of mRNA
to facilitate cap-dependent translation. Besides cap-dependent
translation, eIF4A1 has also been reported to play an important
role in cell proliferation and DNA viral replication [9–14].
In our study, miR-US25-2-3p is the ﬁrst identiﬁed miRNA to
regulate eIF4A1 expression. More importantly, we demonstrated
for the ﬁrst time that over-expression of miR-US25-2-3p has a neg-
ative effect on HCMV replication by inhibiting eIF4A1 protein
expression. We found that the natural miR-US25-2-3p expression
and HCMV copy number in infected MRC-5 cells showed time-
dependent increase, and eIF4A1 protein expression also increased
after HCMV infection compared to uninfected cells, which is con-
sistent with previous reports [14,25,26]. No obvious correlation
was observed between miR-US25-2-3p and eIF4A1 expression dur-
ing natural HCMV infection. However, silencing of miR-US25-2-3p
by its inhibitor induced increased eIF4A1 protein expression and
HCMV DNA synthesis in infected cells. Moreover, HCMV DNA cop-
ies were negatively associated with miR-US25-2-3p over-expres-
sion, and positively associated with eIF4A1 protein levels in the
in vitro transfection study. Therefore, lower expression of eIF4A1
regulated by miR-US25-2-3p may be a novel mechanism underly-
ing HCMV replication decrease caused by miR-US25-2-3p over-
expression. In addition, the fact that over-expression of miR-
US25-2-3p and knockdown of eIF4A1 by speciﬁc siRNA inhibited
eIF4A1-dependent translation, cell growth and genomic DNA syn-
thesis may contribute to the reduction of HCMV replication. Our
ﬁndings suggest that inhibition of HCMV replication by high level
of miR-US25-2-3p is probably mediated by suppression of eIF4A1
in host cells.
Previous studies reveal that HCMV does not suppress the trans-
lation of host polypeptides. Many regulators, such as HCMV pro-
tein immediate-early (IE) 1, IE2 [14] and UL69 [27], can increase
translation initiation factor concentration to maintain effective vir-
al replication, among which, the effect of miR-US25-2-3p could be
relatively weak. As was seen in our study, the inhibitory effect of
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natural expressed miR-US25-2-3p were not obvious, which was
different from the observations in cells transfected with pre-miR-
US25-2-3p. Moreover, considering other putative targets of miR-
US25-2-3p, such as cell growth positive regulator-versican, tran-
script variant 3 (VCAN V3) [28] and negative regulators-transforming
growth factor, beta-induced, 68kDa (TGFBI) [29] and apoptosis in-
duced factor- immediate early response 3 (IER3) [30] might be in-
volved in the regulation of viral DNA synthesis, the integrated
effect of miR-US25-2-3p may be relatively mild. In our study,
miR-25-2-3p over-expression only reduced HCMV copy number
by 2 to 5-folds. So far, there has been no evidence that HCMV miR-
NAs are expressed during latency and would thus be present in a
cell prior to the advent of lytic replication. Therefore, we suggests
that miR-US-25-2-3p has only been shown to inhibit HCMV repli-
cation if expressed prior to infection, e.g., by transfection. Further
study is needed to understanding the biological relevance of
miR-US25-2-3p in the course of HCMV infection.
In conclusion, eIF4A1 is the ﬁrst identiﬁed target mRNA of miR-
US25-2-3p, and the inhibition of HCMV replication by miR-US25-
2-3p over-expression is mediated by suppression of eIF4A1 in host
cells. Although the biological signiﬁcance of miR-US25-2-3p on
inhibition of HCMV replication and underlying mechanisms regu-
lating miR-US25-2-3p expression in infected host cells remains un-
known, the discovery of negative effects of miR-US25-2-3p on viral
replication may help to develop a miRNA-based therapeutic ap-
proach for reducing the severity of virus infection in immunocom-
promised individuals.
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